European Archives - Page 1051 of 1109 - European Medical Journal

Continue
EMJ
2 Jun 2015

Early-Stage Trial of Nivolumab in Advanced Liver Cancer

Findings from a phase I/II study suggest that nivolumab is safe and effective in advanced liver cancer. Based on the results of the phase I part of the…
EMJ
2 Jun 2015

Genomic Marker Predicts Anti-PD-1 Response in Several Cancers

A phase II study identified the first genomic marker – mismatch repair (MMR) deficiency – to predict response to the anti-PD-1 antibody pembrolizumab…
EMJ
2 Jun 2015

Pembrolizumab Shows Promising Activity Against Head and Neck Cancer

A 132-patient study indicates that pembrolizumab immunotherapy is effective for patients with recurrent or metastatic head and neck cancer (HNC). The…
EMJ
2 Jun 2015

Nivolumab Extends Survival for Patients With the Most Common Lung Cancer

Findings from a randomised phase III study indicate that PD-1 immunotherapy is an effective treatment option for patients with non-squamous, non-small…
EMJ
2 Jun 2015

An introduction to ASCO 2015 by the 2014-15 president, Peter Paul Yu, MD, FACP, FASCO

Peter Paul Yu, MD, FACP, FASCO introduces ASCO 2015 and the conference themes – how to utilise data, to transform it into learning to impact patient care.
EMJ
1 Jun 2015

Mediterranean Diet for a Healthy Mind

MEDITERRANEAN diets, supplemented with additional portions of antioxidant-rich extra virgin olive oil or mixed nuts, could protect cognitive functioning…
EMJ
1 Jun 2015

Head Transplants: No Longer Science Fiction But a Step Closer to Reality?

HUMAN head transplants have, until recently, been nothing more than science fiction, but Dr Sergio Canavero, Director of the Turin Advanced…
EMJ
29 May 2015

All Forms of Smoking Are Bad for the Heart

Sophia Antipolis, 31 May 2015: All forms of smoking are bad for the heart, the European Society of Cardiology (ESC) warned today…
EMJ
27 May 2015

Experts across Europe Call for Earlier Detection of Oesophageal Cancer in a Bid to Improve Survival Rates

(May 21, 2015) Recent estimates indicate that more than 34,000 new cases of oesophageal cancer are recorded across Europe annually, with incidence…
EMJ
26 May 2015

New Data on BIOTRONIK Orsiro Hybrid Drug-Eluting Stent Demonstrates Enhanced Safety and Three-Times Reduced Risk of Stent Thrombosis

BUELACH, Switzerland, May 26, 2015—BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced that positive new…
We’ve noticed you’re accessing
from North/South America.